Clinical Trial: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
Hepatitis B, Chronic
Fibrosis, Liver
Diabetes Mellitus, Type 2
Study Type: Interventional
Official Title: Prospective, Multicenter, Randomized, and Comparative Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant He
Brief Summary:
An exploratory comparison of changes in liver fibrosis through glycemic control within and between groups after administration of Pioglitazone and Evogliptin in chronic hepatitis B patients with type 2 diabetes and liver fibrosis
Read more